<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Diffusion Pharmaceuticals &#187; Staff</title>
	<atom:link href="http://www.diffusionpharma.com/category/staff/feed" rel="self" type="application/rss+xml" />
	<link>http://www.diffusionpharma.com</link>
	<description></description>
	<lastBuildDate>Mon, 06 Feb 2012 14:39:17 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.1</generator>
		<item>
		<title>Diffusion Pharmaceuticals LLC Announces Addition of Dr. David R. Jones as Chief Medical Officer, and Dr. Guy M. Chisolm Joins its Scientific Advisory Board</title>
		<link>http://www.diffusionpharma.com/progress/diffusion-pharmaceuticals-llc-announces-addition-of-dr-david-r-jones-as-chief-medical-officer-and-dr-guy-m-chisolm-joins-its-scientific-advisory-board</link>
		<comments>http://www.diffusionpharma.com/progress/diffusion-pharmaceuticals-llc-announces-addition-of-dr-david-r-jones-as-chief-medical-officer-and-dr-guy-m-chisolm-joins-its-scientific-advisory-board#comments</comments>
		<pubDate>Mon, 04 Jan 2010 17:45:10 +0000</pubDate>
		<dc:creator>Tracey Danner</dc:creator>
				<category><![CDATA[Board]]></category>
		<category><![CDATA[Progress]]></category>
		<category><![CDATA[Staff]]></category>

		<guid isPermaLink="false">http://www.diffusionpharma.com/?p=135</guid>
		<description><![CDATA[CHARLOTTESVILLE, VA – Wednesday, January 6, 2010 – Diffusion Pharmaceuticals LLC, a clinical-stage drug-development company commercializing first-in-class drugs to treat serious or life-threatening unmet medical conditions, today announced that David R. Jones, M.D., has joined its staff as Chief Medical Officer and member of its Scientific Advisory Board (SAB). In addition, Guy M. Chisolm, Ph.D., [...]]]></description>
		<wfw:commentRss>http://www.diffusionpharma.com/progress/diffusion-pharmaceuticals-llc-announces-addition-of-dr-david-r-jones-as-chief-medical-officer-and-dr-guy-m-chisolm-joins-its-scientific-advisory-board/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Diffusion Pharmaceuticals Announces Formation of Scientific Advisory Board</title>
		<link>http://www.diffusionpharma.com/board/diffusion-pharmaceuticals-announces-formation-of-scientific-advisory-board</link>
		<comments>http://www.diffusionpharma.com/board/diffusion-pharmaceuticals-announces-formation-of-scientific-advisory-board#comments</comments>
		<pubDate>Thu, 26 Apr 2007 14:42:36 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Board]]></category>
		<category><![CDATA[Staff]]></category>

		<guid isPermaLink="false">http://208.109.62.72/?p=73</guid>
		<description><![CDATA[CHARLOTTESVILLE, VA – April 26, 2007 – Diffusion Pharmaceuticals LLC, a clinical-stage drug discovery and development company pioneering a revolutionary approach to the treatment of life-threatening diseases, today announced that it has formed a Scientific Advisory Board (SAB) to advise the Company on its clinical development programs. The SAB, comprised of four noted scientists and [...]]]></description>
		<wfw:commentRss>http://www.diffusionpharma.com/board/diffusion-pharmaceuticals-announces-formation-of-scientific-advisory-board/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Diffusion Pharmaceuticals Strengthens Management Team with Appointment of Matthew W. Hantzmon as Vice President, Business Development</title>
		<link>http://www.diffusionpharma.com/staff/diffusion-pharmaceuticals-strengthens-management-team-with-appointment-of-matthew-w-hantzmon-as-vice-president-business-development</link>
		<comments>http://www.diffusionpharma.com/staff/diffusion-pharmaceuticals-strengthens-management-team-with-appointment-of-matthew-w-hantzmon-as-vice-president-business-development#comments</comments>
		<pubDate>Tue, 07 Nov 2006 14:46:49 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Staff]]></category>

		<guid isPermaLink="false">http://208.109.62.72/?p=76</guid>
		<description><![CDATA[CHARLOTTESVILLE, VA – November 7, 2006 – Diffusion Pharmaceuticals LLC, a drug discovery and development company pioneering a revolutionary approach to treat life-threatening diseases, today announced that it has appointed Matthew W. Hantzmon to the new position of Vice President, Business Development. Mr. Hantzmon, a senior executive with a successful record in medical technology and [...]]]></description>
		<wfw:commentRss>http://www.diffusionpharma.com/staff/diffusion-pharmaceuticals-strengthens-management-team-with-appointment-of-matthew-w-hantzmon-as-vice-president-business-development/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

